| MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction FJ Nassar, R Nasr, R Talhouk Pharmacology & therapeutics 172, 34-49, 2017 | 212 | 2017 |
| Escherichia coli O157:H7—Clinical aspects and novel treatment approaches EA Rahal, N Kazzi, FJ Nassar, GM Matar Frontiers in cellular and infection microbiology 2, 138, 2012 | 119 | 2012 |
| Gut microbiome: a promising biomarker for immunotherapy in colorectal cancer S Temraz, F Nassar, R Nasr, M Charafeddine, D Mukherji, ... International journal of molecular sciences 20 (17), 4155, 2019 | 116 | 2019 |
| Exosomal non coding RNA in LIQUID biopsies as a promising biomarker for colorectal cancer A Baassiri, F Nassar, D Mukherji, A Shamseddine, R Nasr, S Temraz International journal of molecular sciences 21 (4), 1398, 2020 | 86 | 2020 |
| The crosstalk between microbiome and immune response in gastric cancer R Nasr, A Shamseddine, D Mukherji, F Nassar, S Temraz International Journal of Molecular Sciences 21 (18), 6586, 2020 | 72 | 2020 |
| Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype EA Rahal, SM Fadlallah, FJ Nassar, N Kazzi, GM Matar Frontiers in cellular and infection microbiology 5, 24, 2015 | 68 | 2015 |
| ATL-derived exosomes modulate mesenchymal stem cells: potential role in leukemia progression J El-Saghir, F Nassar, N Tawil, M El-Sabban Retrovirology 13, 1-13, 2016 | 61 | 2016 |
| Effects of Subinhibitory Concentrations of Antimicrobial Agents on Escherichia coli O157:H7 Shiga Toxin Release and Role of the SOS Response FJ Nassar, EA Rahal, A Sabra, GM Matar Foodborne pathogens and disease 10 (9), 805-812, 2013 | 47 | 2013 |
| A signature of four circulating microRNAs as potential biomarkers for diagnosing early-stage breast cancer MM Itani, FJ Nassar, AH Tfayli, RS Talhouk, GK Chamandi, ARS Itani, ... International journal of molecular sciences 22 (11), 6121, 2021 | 43 | 2021 |
| miRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study FJ Nassar, M El Sabban, NK Zgheib, A Tfayli, F Boulos, M Jabbour, ... PloS one 9 (9), e107566, 2014 | 43 | 2014 |
| Circulating miRNA as biomarkers for colorectal cancer diagnosis and liver metastasis FJ Nassar, ZS Msheik, MM Itani, RE Helou, R Hadla, F Kreidieh, ... Diagnostics 11 (2), 341, 2021 | 40 | 2021 |
| Ascorbic acid in colon cancer: from the basic to the clinical applications I El Halabi, R Bejjany, R Nasr, D Mukherji, S Temraz, FJ Nassar, ... International journal of molecular sciences 19 (9), 2752, 2018 | 40 | 2018 |
| Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon R Hanna-Wakim, H Chehab, I Mahfouz, F Nassar, M Baroud, M Shehab, ... Vaccine 30, G11-G17, 2012 | 40 | 2012 |
| microRNA expression in ethnic specific early stage breast cancer: an integration and comparative analysis FJ Nassar, R Talhouk, NK Zgheib, A Tfayli, M El Sabban, NS El Saghir, ... Scientific reports 7 (1), 16829, 2017 | 37 | 2017 |
| Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction FJ Nassar, ZS Msheik, RR Nasr, SN Temraz Clinical Epigenetics 13 (1), 111, 2021 | 36 | 2021 |
| Peripheral blood-based biopsy for breast cancer risk prediction and early detection FJ Nassar, G Chamandi, MA Tfaily, NK Zgheib, R Nasr Frontiers in Medicine 7, 28, 2020 | 36 | 2020 |
| Hepatocellular carcinoma immunotherapy and the potential influence of gut microbiome S Temraz, F Nassar, F Kreidieh, D Mukherji, A Shamseddine, R Nasr International journal of molecular sciences 22 (15), 7800, 2021 | 32 | 2021 |
| Genotypes and serotype distribution of macrolide resistant invasive and non- invasive Streptococcus pneumoniae isolates from Lebanon N Taha, GF Araj, RH Wakim, SS Kanj, ZA Kanafani, A Sabra, ... Annals of Clinical Microbiology and Antimicrobials 11, 1-6, 2012 | 28 | 2012 |
| Inflammatory markers and microRNAs: the backstage actors influencing prognosis in colorectal cancer patients R Nasr, M Salim Hammoud, F Nassar, D Mukherji, A Shamseddine, ... International Journal of Molecular Sciences 19 (7), 1867, 2018 | 25 | 2018 |
| Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors R El Eit, AR Itani, F Nassar, N Rasbieh, M Jabbour, A Santina, G Zaatari, ... Cancer 125 (16), 2818-2828, 2019 | 19 | 2019 |
